Louai Alrata
Research Subjects
Louai Alrata has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Tarek Alhamad
Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri
5 shared publications - Dema Yaseen Alsabbagh
Division of Nephrology, Washington University School of Medicine in St. Louis, 660 Euclid Ave., Mail Stop 8126-05-06, St. Louis, MO 63110, USA
3 shared publications - Casey A. Dubrawka
Department of Pharmacy Barnes‐Jewish Hospital St. Louis Missouri USA
2 shared publications - Omar Alomar
Department of Surgery Washington University in St. Louis St. Louis Missouri USA
2 shared publications - Tarek Abdulhadi
Department of Medicine, Division of Nephrology, Washington University School of Medicine, St. Louis, MO63110, USA
2 shared publications - Bekir Tanriover
University of Arizona, Tucson, United States, USA
1 shared publication
Latest Publications
- Open Access
- 2 September 2024
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 31 (5) , 476-482
Management of Failing Kidney and Pancreas Transplantations
- 2 September 2024
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 31 (5) , 476-482
Open AccessManagement of Failing Kidney and Pancreas Transplantations
- Open Access
- 27 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (1) , 123-133
Recurrent atypical antiglomerular basement membrane nephritis in the kidney transplant
- 27 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (1) , 123-133
Open AccessRecurrent atypical antiglomerular basement membrane nephritis in the kidney transplant
- 21 September 2023
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 24 (14) , 771-780
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation
The early detection of acute rejection in the allograft is important as it provides an opportunity for timely therapeutic intervention in order to preserve graft function and achieve longer graft s...
- 21 September 2023
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 24 (14) , 771-780
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation
The early detection of acute rejection in the allograft is important as it provides an opportunity for timely therapeutic intervention in order to preserve graft function and achieve longer graft s...
- Open Access
- 26 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4916
Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
Despite the advances in immunosuppressive medications, antibody-mediated rejection (AMR) continues to be a major cause of kidney allograft failure and remains a barrier to improving long-term allograft survival. Recently, there have been significant advances in the understanding of the pathophysiological process of AMR, along with the development of new therapeutic options. Additionally, surveillance protocols with donor-derived cell-free DNA and gene profile testing have been established, leading to the early detection of AMR. A multitude of clinical trials are ongoing, opening numerous opportunities for improving outcome in kidney transplant recipients. In this brief review, we discuss the emerging therapies for managing both active and chronic active AMR and highlight the ongoing clinical trials.
- 26 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4916
Open AccessEmerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
Despite the advances in immunosuppressive medications, antibody-mediated rejection (AMR) continues to be a major cause of kidney allograft failure and remains a barrier to improving long-term allograft survival. Recently, there have been significant advances in the understanding of the pathophysiological process of AMR, along with the development of new therapeutic options. Additionally, surveillance protocols with donor-derived cell-free DNA and gene profile testing have been established, leading to the early detection of AMR. A multitude of clinical trials are ongoing, opening numerous opportunities for improving outcome in kidney transplant recipients. In this brief review, we discuss the emerging therapies for managing both active and chronic active AMR and highlight the ongoing clinical trials.
- Open Access
- 12 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 629-635
The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications
- 12 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 629-635
Open AccessThe association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications